Insider filing · CSTL
Frank Stokes
Chief Financial Officer
profile →
Castle Biosciences, Inc.
CSTL · Healthcare · 59 filings in 24 months
ticker →
Frank Stokes sold $742K of Castle Biosciences (CSTL)
Executed Aug 14, disclosed Aug 18, 4 days later.
Value, as filed
$742K
24,908 sh × $29.77
Executed
Aug 14
the trade date, as filed
Disclosed
Aug 18
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FSFrank Stokes (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $742K of CSTL (24,908 sh × $29.77, as filed), executed Aug 14.
The name
CSTLHealthcare · Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Frank Stokes in CSTL
CSTLSALE
Castle Biosciences, Inc.
$168K6,001 sh × $27.98
Exec Mar 5
Filed Mar 9 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $145K
5,300 sh × $27.32
Exec Mar 3
Filed Mar 5 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $168K
4,496 sh × $37.45
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $189K
5,388 sh × $35.08
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $215K
8,046 sh × $26.70
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. $183K
6,123 sh × $29.87
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET